Fidelity Disruptive Medicine ETF
FMED
8 hedge funds and large institutions have $32.6M invested in Fidelity Disruptive Medicine ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
3% more capital invested
Capital invested by funds: $31.5M → $32.6M (+$1.07M)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
1.15% less ownership
Funds ownership: 61.35% → 60.2% (-1.1%)
11% less funds holding
Funds holding: 9 → 8 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$725K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$513K |
| 3 |
GEA
Glen Eagle Advisors
Kingston,
New Jersey
|
+$2.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$1.83M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.4K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$2.66K |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$993 |
| 5 |
Morgan Stanley
New York
|
-$222 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $18.9M | +$513K | +20,744 | +3% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $12.7M | +$725K | +29,339 | +6% |
|
|
3
Jane Street
New York
| $979K | -$1.83M | -73,891 | -66% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $4.13K | – | – | – |
|
|
CPBTD
5
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.45K | +$2.4K | +97 | New |
|
|
GEA
6
Glen Eagle Advisors
Kingston,
New Jersey
| $2.3K | +$2.22K | +90 | New |
|
|
DF
7
Dunhill Financial
London,
United Kingdom
| $1.39K | – | – | – |
|
|
8
Morgan Stanley
New York
| $230 | -$222 | -9 | -50% |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$14.4K | -596 | Closed |
|
|
ASN
10
Advisory Services Network
Atlanta,
Georgia
| – | -$2.66K | -110 | Closed |
|
|
HI
11
Harbour Investments
Madison,
Wisconsin
| – | -$993 | -41 | Closed |
|
FMED Hedge Fund Activity: Q1 2024 in Review
8 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q1 2024, worth a combined $32.6M — up 3.4% from $31.5M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FMED and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Wealth Enhancement Advisory Services, adding an estimated $725K. The largest seller was Jane Street, cutting an estimated $1.83M.
- 8 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q1 2024, down from 9 in Q4 2023.
- Funds reported $32.6M of Fidelity Disruptive Medicine ETF stock for Q1 2024, up 3.4% quarter-over-quarter.
- 2 funds opened new Fidelity Disruptive Medicine ETF positions in Q1 2024 and 3 closed out, a net change of -1 holder.
- The largest Fidelity Disruptive Medicine ETF buyer in Q1 2024 was Wealth Enhancement Advisory Services, an estimated $725K added.
- The largest Fidelity Disruptive Medicine ETF seller in Q1 2024 was Jane Street, an estimated $1.83M sold.
Based on aggregated 13F filings for Q1 2024.